Buy Mediators in the Cardiovascular System by Cecil R. Pace-Asciak
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Medicine & Health Science textbooks > Medicine: general issues > Medical equipment and techniques > Medical research > Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)
Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)

Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)


     0     
5
4
3
2
1



Available


X
About the Book

This text contains the latest data in the field of the study of chemical signalling. Significant progress has been made during the last few years and a number of intercellular mediators have been structurally identified and their regulation analyzed. These developments have a major impact on cardiovascular pharmacology - this includes both the molecular design of new drugs, together with an improved understanding of the actions of established compounds. In this volume, international experts address relevant aspects of recent research and emerging themes in the field of myocardial ischemia. Particular emphasis is placed upon the regulation, function and pharamcological modification of eicosanoids, nitric oxide and endothelins, with an outlook on future drug developments.

Table of Contents:
Prostaglandins and related eicosanoids.- Regulation of prostanoid-synthesis in the cardiovascular system.- Molecular regulation and augmentation of prostacyclin biosynthesis.- Testosterone regulation of platelet and vascular thromboxane A2 receptors.- Formation of 8-iso-prostaglandin F2? by human platelets.- Regulation of prostaglandin receptors in myocardial ischemia.- Hydroxylated 22-carbon fatty acids in platelet and vascular smooth muscle function: Interference with TXA2/PGH2 receptors.- Increased permeability of bovine aortic endothelial cell monolayers in response to a thromboxane A2-mimetic.- Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane.- The induction of cyclooxygenase-2 elicited by endotoxin in endothelial cells and macrophages is inhibited by prostaglandin E1 and 13,14-dihydro prostaglandin E1.- Effects of prostaglandin E1, prostaglandin E0 and SPM 206 on isolated human coronary arteries.- Vasodilator effects of PGE1 in the coronary and systemic circulation of the rat are mediated by ATP-sensitive potassium (K+) channels.- Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets.- Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization.- The cardioprotective actions of iloprost in myocardial ischemia of the rabbit can be separated from its vasodilatory effects mediated by KATP+-channel opening.- Cicaprost inhibits collagen-induced platelet accumulation in rat lungs for some hours..- Nitric oxide.- The endothelial cell nitric oxide synthase: Is it really constitutively expressed?.- Kinin-mediated activation of endothelial nitric oxide formation: Possible role during myocardial ischemia.- Metabolism and excretion of nitric oxide in man: Basal studies and clinical applications.- Nitric oxide mediates microvascular permeability in the isolated perfused rat mesentery?.- Interplay of nitric oxide and histamine in the regulation of coronary reactive hyperemia and coronary autoregulation.- Exogenously supplied nitric oxide influences the dilation of the capillary microvasculature in vivo.- Effects of prolonged L-arginine administration on blood pressure in patients with essential hypertension (EH).- A neutrophil-derived nitric oxide-synthase (NOS) inhibitor.- Elevation of circulating nitric oxide: Its effects on hemodynamics and vascular smooth muscle cell proliferation in rats.- Activation of endothelial guanylate cyclase inhibits cellular reactivity.- Nitric oxide - related drugs.- Comparison of the vasorelaxing effect of different nitrovasodilators in conductive arterial and venous blood vessels.- Glyceryl trinitrate but not spontaneous nitric oxide donors preserve myocardial function and cell integrity in ischemic rabbit hearts.- Effects of nitric oxide donors, SIN-1 and GEA 3175 on prostacyclin and cGMP synthesis in cultured rat endothelial cells.- Effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate in experimental atherosclerosis.- Effect of nitric oxide donors on rat bronchial muscle in vitro.- Rapid tolerance to formation of authentic nitric oxide from nitroglycerin in vivo.- The exercise-induced increase in plasma levels of endothelin-1 is enhanced in patients with atherosclerotic coronary artery disease. Modulation by pentaerithrityltetranitrat (PETN).- Vasoactive peptides and lipid mediators.- Clinical relevance of endothelial dysfunction in cardiovascular disorders.- Endothelin and endothelin antagonists: Pharmacology and clinical implications.- Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors.- The effects of intracellular Ca2+ concentration and hypoxia on basal endothelin-1 secretion by cultured porcine aortic endothelial cells.- The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: Possible explanation for hypoxic coronary spasm development.- Pituitary adenylate cyclase activating peptides are endothelium-independent dilators of human and porcine coronary arteries.- Coupling of hepoxilin A3-specific binding with calcium-mobilizing actions in human neutrophils.- Role of intracellular calcium in the regulation of phospholipase A2 in fMet-Leu-Phechallenged human polymorph neutrophils.- Thrombin receptor activating peptide - induced cellular effects: Comparative studies on human platelet activation and endothelium-dependent relaxation of porcine pulmonary arteries.- Inositol 1,4,5-triphosphate and protein kinase C are involved in thrombin and TRAP-induced vascular smooth muscle contraction.- Isolation and functional characterization of DNA-derived aptamers that act as thrombin inhibitors in human platelets and coagulation assays.- Defibrotide's activity on leukocytes and platelets in rabbits with diet-induced atherosclerosis.- Author Index.- Keyword Index.


Best Sellers


Product Details
  • ISBN-13: 9783764351304
  • Publisher: Birkhauser Verlag AG
  • Publisher Imprint: Birkhauser Verlag AG
  • Height: 235 mm
  • Returnable: N
  • Sub Title: Regional Ischemia
  • Width: 165 mm
  • ISBN-10: 3764351306
  • Publisher Date: 20 Dec 1994
  • Binding: Hardback
  • Language: English
  • Series Title: v. 45 Agents and Actions, Supplements
  • Weight: 757 gr


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)
Birkhauser Verlag AG -
Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Mediators in the Cardiovascular System: Regional Ischemia(v. 45 Agents and Actions, Supplements)

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!